Antonino Buzzanca
Overview
Explore the profile of Antonino Buzzanca including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Accinni T, Frascarelli M, Cordellieri P, Kotzalidis G, Fanella M, Di Bonaventura C, et al.
J Intellect Disabil Res
. 2024 Nov;
69(3):177-192.
PMID: 39614621
Background: The 22q11.2 deletion syndrome (22q11.2DS) entails intellectual disabilities and higher risk of psychotic disorders. Neurocognitive deficits predict real-life functioning of schizophrenic patients. We investigated real-life functioning in 22q11.2DS, aiming...
2.
Accinni T, Buzzanca A, Frascarelli M, Carlone L, Ghezzi F, Kotzalidis G, et al.
Schizophr Bull Open
. 2024 Aug;
3(1):sgab049.
PMID: 39144801
Background: 22q11.2 Deletion Syndrome (22q11DS) represents one of the most important genetic risk factors for schizophrenia (SCZ) and a reliable biological model to study endophenotypic characters of SCZ. The aim...
3.
Frascarelli M, Accinni T, Buzzanca A, Carlone L, Ghezzi F, Moschillo A, et al.
J Neuropsychol
. 2023 May;
17(3):564-583.
PMID: 37159847
Patients with the 22q11.2 deletion syndrome (DS) show an increased risk of developing a psychotic illness lifetime. 22q11.2DS may represent a reliable model for studying the neurobiological underpinnings of schizophrenia....
4.
Frascarelli M, Accinni T, Buzzanca A, Di Bonaventura C, Fanella M, Putotto C, et al.
Riv Psichiatr
. 2023 Jan;
58(1):10-20.
PMID: 36715578
Background: The 22q11.2 Deletion Syndrome (22q11.2DS) is considered the most reliable biological model to study genetic vulnerability to schizophrenia. It appears useful to investigate neuroanatomical characteristics of people with 22q11.2DS...
5.
Buzzanca A, Accinni T, Frascarelli M, Troisi E, Kotzalidis G, Di Bonaventura C, et al.
Early Interv Psychiatry
. 2022 Mar;
17(1):76-84.
PMID: 35347860
Background: Social cognition (SC) deficits and of its facial emotion expression (FEE) component have been described in 22q11.2 Deletion Syndrome (22q11.2DS), a high-risk for schizophrenia (SCZ) systemic genetic syndrome. Correlations...
6.
Accinni T, Frascarelli M, Ghezzi F, Panzera A, Buzzanca A, Fanella M, et al.
Clin Case Rep
. 2021 Jun;
9(5):e04134.
PMID: 34084508
Despite entailing more severe and uncommon side effects in 22q11.2DS compared to idiopathic schizophrenia, we strongly believe that clozapine should continue to be considered the gold standard for all treatment-resistant...
7.
Rocca P, Brasso C, Montemagni C, Bellino S, Rossi A, Bertolino A, et al.
NPJ Schizophr
. 2021 Feb;
7(1):11.
PMID: 33589645
A consensus has not yet been reached regarding the accuracy of people with schizophrenia in self-reporting their real-life functioning. In a large (n = 618) cohort of stable, community-dwelling schizophrenia...
8.
Frascarelli M, Padovani G, Buzzanca A, Accinni T, Carlone L, Ghezzi F, et al.
Ann Ist Super Sanita
. 2020 Apr;
56(1):107-113.
PMID: 32242542
Introduction: 22q11.2 microdeletion syndrome (22q11DS) is associated with a 25% risk of psychotic onset. Materials And Methods: The sample consist of 120 subjects: 39 schizophrenics (SCZ); 20 siblings of schizophrenic...
9.
Fanella M, Frascarelli M, Lambiase C, Morano A, Unolt M, Liberati N, et al.
J Med Genet
. 2019 Sep;
57(3):151-159.
PMID: 31506323
Background: 22q11.2 deletion syndrome (22q11.2DS) is considered as the genetic model of schizophrenia. However, its polymorphic nature has led researchers to further investigate its neuropsychiatric manifestations. Methods: We enrolled 56...
10.
Zhao Y, Guo T, Fiksinski A, Breetvelt E, McDonald-McGinn D, Crowley T, et al.
Am J Med Genet A
. 2018 Oct;
176(10):2172-2181.
PMID: 30289625
The 22q11.2 deletion syndrome is caused by non-allelic homologous recombination events during meiosis between low copy repeats (LCR22) termed A, B, C, and D. Most patients have a typical LCR22A-D...